{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:53:52Z","timestamp":1777704832968,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.transproceed.2021.02.005","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T19:03:48Z","timestamp":1616180628000},"page":"1350-1354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful Salvage Therapy by Second Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in a Severe Aplastic Anemia Patient Presenting Donor-Specific Anti-HLA Antibodies After Graft Failure From Matched Sibling Donor HSCT: A Case Report and\u00a0Review"],"prefix":"10.1016","volume":"53","author":[{"given":"Yejun","family":"Si","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiru","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.02.005_bib0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0002","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/539825","article-title":"The presence of anti-HLA antibodies before and after allogeneic hematopoietic stem cells transplantation from HLA-mismatched unrelated donors","volume":"2012","author":"Koclega","year":"2012","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0004","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","article-title":"High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation","volume":"88","author":"Ciurea","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bmt.2011.131","article-title":"Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT","volume":"47","author":"Yoshihara","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0006","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1182\/blood-2011-06-362111","article-title":"Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation","volume":"118","author":"Ciurea","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0007","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","article-title":"The impact of anti-HLA antibodies on unrelated cord blood transplantations","volume":"116","author":"Takanashi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0008","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3324\/haematol.2012.077685","volume":"98","author":"Ruggeri","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0009","first-page":"269","article-title":"Impact of a full-time donor management protocol on donors\u2019 liver biopsy findings: progress to date","volume":"15","author":"Mojtabaee","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","article-title":"Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0011","first-page":"858","article-title":"Bone marrow transplantation for severe aplastic anemia: has outcome improved?","volume":"90","author":"Passweg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0012","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bbmt.2009.01.023","article-title":"Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia","volume":"15","author":"Horan","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0013","series-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","first-page":"579","article-title":"Severe aplastic anemia and PNH","author":"Latour","year":"2019"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fimmu.2016.00030","article-title":"Alloantibody generation and effector function following sensitization to human leukocyte antigen","volume":"7","author":"Hickey","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJMc1313506","article-title":"Complement-binding anti-HLA antibodies and kidney transplantation","volume":"370","author":"Lobo","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0016","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","article-title":"Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets","volume":"8","author":"Chang","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0017","first-page":"219","article-title":"Anti-HLA antibody levels are associated with the risk of graft failure after allogeneic hematopoietic stem cell transplant","volume":"15","author":"Basturk","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0018","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1537-2995.2010.02589.x","article-title":"Identification of specificities of antibodies against human leukocyte antigens in blood donors","volume":"50","author":"Endres","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0019","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1423-0410.2010.01420.x","article-title":"Prevalence of leucocyte antibodies in the Dutch donor population","volume":"100","author":"Middelburg","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0020","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.humimm.2009.06.020","article-title":"Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood","volume":"70","author":"El-Awar","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0021","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"Natural\" human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0022","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3346\/jkms.2002.17.4.468","article-title":"Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia","volume":"17","author":"Chung","year":"2002","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0023","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0198-8859(89)90003-7","article-title":"Laboratory and clinical management of the highly sensitized organ transplant recipient","volume":"26","author":"Braun","year":"1989","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0024","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.exphem.2012.06.003","article-title":"Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens","volume":"40","author":"Detrait","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0025","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41409-018-0154-0","article-title":"Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia","volume":"53","author":"Yahng","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0026","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bbmt.2011.06.004","article-title":"The role of anti-HLA antibodies in hematopoietic stem cell transplantation","volume":"17","author":"Focosi","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.005_bib0027","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/bmt.2014.331","article-title":"Donor HLA-specific Abs: to BMT or not to BMT?","volume":"50","author":"Leffell","year":"2015","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521001160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521001160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:38:24Z","timestamp":1758577104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0041134521001160"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.02.005","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Salvage Therapy by Second Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in a Severe Aplastic Anemia Patient Presenting Donor-Specific Anti-HLA Antibodies After Graft Failure From Matched Sibling Donor HSCT: A Case Report and\u00a0Review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}